[{"Assets_0_Q3_USD":1335900000.0,"CIK":"899923","CommonStockSharesConverted_0_Q3_shares":79700000.0,"CommonStockSharesOutstanding_0_Q3_shares":79700000.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":0.31,"EarningsPerShareBasic_3_Q3_USD":-0.25,"EarningsPerShareDiluted_1_Q3_USD":0.3,"EarningsPerShareDiluted_3_Q3_USD":-0.25,"Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":28100000.0,"NetIncomeLossConverted_1_Q3_USD":24600000.0,"NetIncomeLossConverted_3_Q3_USD":-19600000.0,"OfficialName":"Myriad Genetics Inc. Common Stock","RevenuesConverted_1_Q3_USD":167300000.0,"RevenuesConverted_3_Q3_USD":529800000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":968500000.0,"StockholdersEquity_0_Q3_USD":968600000.0,"Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":81500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":77300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":78800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":77300000.0,"filed":"20211104","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2021.0","name":"MYRIAD GENETICS INC","period":"20210930","qtrs":"0","uom":"USD"}]